SKI Market

A+| A| A-|

Indian Indices

Sensex

75,508.54 899.56
( 1.21%)

Global Indices

Nasdaq

49,714.12 -67.45
(-0.14%)

Dow Jones

7,466.35 44.39
(0.60%)

Hang Seng

62,791.91 -480.20
(-0.76%)

Nikkei 225

10,300.99 35.67
(0.35%)

Forex

USD-INR

95.60 0.47
(0.49%)

EUR-INR

112.29 0.30
(0.26%)

GBP-INR

129.50 0.02
(0.02%)

JPY-INR

0.61 0.00
(0.19%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

375.7898972

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

32.79

105592.45

EPS(TTM)

Face Value()

Div & Yield %

38.58

0.63

Back

KSB consolidated net profit declines 22.87% in the March 2026 quarter

Apr 30,2026

Net profit of KSB declined 22.87% to Rs 39.80 crore in the quarter ended March 2026 as against Rs 51.60 crore during the previous quarter ended March 2025. Sales rose 0.99% to Rs 601.30 crore in the quarter ended March 2026 as against Rs 595.40 crore during the previous quarter ended March 2025.

Particulars	Quarter Ended
	Mar. 2026	Mar. 2025	% Var.
Sales	601.30	595.40	1
OPM %	8.45	11.37	-
PBDT	67.80	82.90	-18
PBT	53.30	69.00	-23
NP	39.80	51.60	-23

75,508.54 899.56 ( 1.21%)

49,714.12 -67.45 (-0.14%)

7,466.35 44.39 (0.60%)

62,791.91 -480.20 (-0.76%)

10,300.99 35.67 (0.35%)

95.60 0.47 (0.49%)

112.29 0.30 (0.26%)

129.50 0.02 (0.02%)

0.61 0.00 (0.19%)